LIC trims stake in Ranbaxy to 6%

Last Updated: Monday, December 23, 2013, 19:06

State-owned LIC has cut its stake in Ranbaxy Laboratories to a little over 6 percent by selling more than two percent stake over the past five years.

No plans to reduce workforce: Ranbaxy

Last Updated: Wednesday, October 2, 2013, 15:11

Pharmaceuticals major Ranbaxy Laboratories Wednesday said it has no plans to reduce its workforce and is focusing on improving performance and productivity.

Daiichi to cooperate with USFDA to resolve Ranbaxy concerns

Last Updated: Tuesday, September 24, 2013, 15:56

On September 16, the US Food and Drug Administration (USFDA) issued an import alert on drugs produced by the company at its Mohali plant in Punjab for violation of current good manufacturing practices.

USFDA increases inspections of drug facilities in India

Last Updated: Tuesday, September 24, 2013, 15:43

The US health regulators, which has been cracking the whip against many Indian pharmaceutical firms, including Ranbaxy Laboratories and Wockhardt, is also recruiting and training additional drugs investigators in India.

Ranbaxy under scanner of other regulators after USFDA alert

Last Updated: Sunday, September 22, 2013, 12:35

The regulators said action will be taken after assessing the FDA's reply.

Ranbaxy seeks to assuage shareholders' worries

Last Updated: Friday, September 20, 2013, 22:46

Drug major Ranbaxy Laboratories Friday sought to assuage concerns of shareholders in the wake of company's stock price taking a hard knock after the US Food and Drug Administration banned the import of drugs from its Mohali plant.

Watson sends patent challenge notice to Ranbaxy for acne drug

Last Updated: Friday, September 20, 2013, 15:30

Drug firm Ranbaxy Laboratories has said its US arm has received a notice from Watson Laboratories Inc, challenging the patent of acne treatment drug Absorica.

Ranbaxy import ban: USFDA found suspected hair, oil in tablets

Last Updated: Wednesday, September 18, 2013, 17:46

Tablets embedded with 'black fibre' that was suspected to be hair from an employee's arm, 'black spots' of oil from machines in tablets and absence of running water in toilets were some observations made by USFDA that has banned import of drugs made at Ranbaxy's Mohali unit.

Certain consent decree terms to apply to Mohali unit: Ranbaxy

Last Updated: Tuesday, September 17, 2013, 19:16

"The FDA also ordered that the Mohali facility be subject to certain terms of the consent decree of permanent injunction entered against Ranbaxy in January 2012," according to United States Food and Drug Administration website.

Ranbaxy shares bounce back; surge over 6%

Last Updated: Tuesday, September 17, 2013, 10:21

In the previous session, shares of Ranbaxy lost over 30 percent, eroding Rs 5,855 crore from its market value.

US import alert on Ranbaxy; Mohali unit part of consent decree

Last Updated: Monday, September 16, 2013, 23:54

"The firm will remain on the import alert until the company complies with U.S. Drug manufacturing requirements, known as current good manufacturing practices (CGMP)," USFDA said in a statement.